GH

Guardant Health, Inc.

Healthcare›Medical - Diagnostics & Research|NASDAQ Global Select|US

Price

$93.83

Market Cap

$12.31B

Beta

1.69

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+32.88%

EPS Growth (YoY)+7.02%

Revenue CAGR 3Y+29.75%

P/E Ratio0.0

PEG Ratio—

FCF Yield-1.79%

Debt / Equity0.00

Interest Coverage-112.2x

No credit card required

Already have an account? Sign in to view the full analysis for GH.